Technologies Available for Licensing
COBALT HEXAMMINE AS A POTENTIAL THERAPEUTIC AGAINST HIV AND/OR EBOLA VIRUS
Hexaamminecobalt(III) chloride, also called Cohex, reduces the extent of viral infection, including difficult to treat infections caused by Ebola virus and HIV. Disclosed are methods for treating a viral infection, comprising administering to a patient a cobalt(III) hexammine compound in an amount effective to reduce an extent of a viral infection. Also disclosed are kits for delivery of a cobalt(III) hexammine compound by injection.
More Detail:Visit USPTO.GOV
Inventor(s):CHANG, E.; HENSLEY, L.; THACH, D.; OLINGER, G.; KNIGHT, A.